270 related articles for article (PubMed ID: 26003023)
1. Restenosis After Drug-Eluting Stent Implantation in a Patient With Polycythemia Vera: Optical Coherence Tomography and Pathological Findings.
Fujino A; Hao H; Kajimoto N; Kawakami R; Imanaka T; Fujii K; Abe T; Ishihara M; Hirota S
JACC Cardiovasc Interv; 2015 Jun; 8(7):e111-2. PubMed ID: 26003023
[No Abstract] [Full Text] [Related]
2. In-stent thin-cap fibroatheroma after drug-eluting stent implantation: ex-vivo evaluation of optical coherence tomography and intracoronary angioscopy.
Fujii K; Hao H; Imanaka T; Kawano T; Takayama T; Hirayama A; Yamada T; Ishibashi-Ueda H; Hirota S; Masuyama T
JACC Cardiovasc Interv; 2014 Apr; 7(4):446-7. PubMed ID: 24656539
[No Abstract] [Full Text] [Related]
3. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
[TBL] [Abstract][Full Text] [Related]
4. Stent failure due to simultaneous aggressive neoatherosclerosis of first- and current-generation drug-eluting stents.
Komukai K; Bernelli C; Sirbu V; Guagliumi G
EuroIntervention; 2015 Nov; 11(7):e1-2. PubMed ID: 26603864
[No Abstract] [Full Text] [Related]
5. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
6. Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis.
Nakajima Y; Itoh T; Morino Y
Catheter Cardiovasc Interv; 2016 Mar; 87(4):E137-42. PubMed ID: 26011018
[TBL] [Abstract][Full Text] [Related]
7. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
8. Rationale and study design of the RESERVOIR trial: a randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus.
Romaguera R; Brugaletta S; Gomez-Lara J; Pinar E; Jiménez-Quevedo P; Gracida M; Roura G; Ferreiro JL; Teruel L; Gómez-Hospital JA; Montanya E; Alfonso F; Valgimigli M; Sabate M; Cequier A
Catheter Cardiovasc Interv; 2015 Mar; 85(4):E116-22. PubMed ID: 25380051
[TBL] [Abstract][Full Text] [Related]
9. Neointimal hemorrhage after drug-eluting stent implantation: possible role for development of neoatherosclerosis.
Hao H; Fujii K; Imanaka T; Kawakami R; Kawano T; Takayama T; Hirayama A; Ishibashi-Ueda H; Masuyama T; Hirota S
JACC Cardiovasc Interv; 2014 Oct; 7(10):1196-7. PubMed ID: 25240549
[No Abstract] [Full Text] [Related]
10. Early restenose in a polymer-free Biolimus A9-coated stent (BioFreedom): A case report based on optical coherence tomography.
Ellert J; Antonsen L; Jensen LO
Cardiovasc Revasc Med; 2017; 18(3):207-211. PubMed ID: 27650886
[TBL] [Abstract][Full Text] [Related]
11. OCT-verified peri-strut low-intensity areas and the extent of neointimal formation after 3 years following stent implantation.
Choi JH; Granada JF; Kim JS; Song YB; Hahn JY; Choi SH; Tellez A; Milewski K; Hong MK; Jang Y; Lee SH; Gwon HC
JACC Cardiovasc Imaging; 2012 Nov; 5(11):1156-60. PubMed ID: 23153916
[No Abstract] [Full Text] [Related]
12. Temporal course of vessel healing and neoatherosclerosis after DES implantation.
Kozuki A; Shinke T; Otake H; Shite J; Nakagawa M; Nagoshi R; Hariki H; Inoue T; Osue T; Taniguchi Y; Nishio R; Hirata KI
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1121-1123. PubMed ID: 24135328
[No Abstract] [Full Text] [Related]
13. Serial OCT Imaging in Vascular Healing After Everolimus-Eluting Stent Implantation.
Yano H; Horinaka S; Ishimitsu T
JACC Cardiovasc Imaging; 2018 Jan; 11(1):147-148. PubMed ID: 28528155
[No Abstract] [Full Text] [Related]
14. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
[TBL] [Abstract][Full Text] [Related]
16. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
[TBL] [Abstract][Full Text] [Related]
17. Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation.
Komatsu T; Yaguchi I; Komatsu S; Nakahara S; Kobayashi S; Sakai Y; Taguchi I
Tex Heart Inst J; 2015 Aug; 42(4):327-32. PubMed ID: 26413014
[TBL] [Abstract][Full Text] [Related]
18. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
[TBL] [Abstract][Full Text] [Related]
19. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
